Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000005849
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000005849
|
|---|---|
| Preferred Name | Nevirapine [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Nevirapine [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Nevirapine [Chemical/Ingredient]
|
| NUI |
N0000005849
|
| Synonym |
6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-
|
| code |
C22042
|
| prefixIRI |
NDF-RT:N0000005849
|
| RxNorm_CUI |
53654
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0029429
|
| MeSH_DUI |
D019829
|
| type | |
| MeSH_Name |
Nevirapine
|
| UMLS_CUI |
C0132326
|
| RxNorm_Name |
Nevirapine
|
| Display_Name |
Nevirapine
|
| MeSH_Definition |
A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV infection and AIDS.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |